CRAC intermediate 1

• Description:

  CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors, detailed information can be found in Patent WO 2010122089 A1, intermediate 9.

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  CRAC Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/CRAC-intermediate-1.html

• Concentration:

  10mM

• Purity:

  98.46

• Solubility:

  DMSO : ≥ 50 mg/mL

• Smiles:

  O=C(C1=C(F)C=CC=C1F)NC2=NNC=C2

• Molecular Formula:

  C10H7F2N3O

• Molecular Weight:

  223.18

• Precautions:

  H302, H315, H319, H335

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  1249343-86-9